Geode Capital Management LLC grew its holdings in Prime Medicine, Inc. (NYSE:PRME – Free Report) by 4.9% during the 3rd ...

CVS Caremark will add Zydus' ZituvioTM and combination products to its template formulary starting January 1, 2025 ...

Zydus Lifesciences reacted sharply to the development in Tuesday's trade with the counter rising 5.23 percent to an intraday high of Rs 1,011.75 per share on the NSE.

Nomura cited higher contribution from diabetes drug Sitaglitptin, which offers a market size of around $300-400 million to be ...

Tim Goyder's Minerals 260 has emerged as the latest junior to ink a big gold deal, offering $166 million for Zijin's 2.3Moz ...

The on-market limb will be effected within certain pre-set parameters and in accordance with the Company's general authority to repurchase shares on-market. The off-market limb will be effected ...

Zydus Lifesciences announces CVS Caremark agreement and FDA priority review for diabetes and Menkes disease treatments.

The GIFT Nifty is indicating a positive start for the day. As of 8:15 AM, the GIFT Nifty was trading in green at 23,811.5, ...